Kyle Piskel - 16 Nov 2022 Form 4/A - Amendment Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Principal Accounting Officer
Signature
/s/ Kyle Piskel by Eric Billings, attorney-in-fact
Issuer symbol
ADPT
Transactions as of
16 Nov 2022
Net transactions value
-$2,723
Form type
4/A - Amendment
Filing time
17 Nov 2022, 15:15:22 UTC
Date Of Original Report
17 Nov 2022
Previous filing
08 Mar 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Sale $2,723 -307 -0.64% $8.87 47,358 16 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding olbigaitons to e funded by a sell to cover transaction and does not represent a discretionary trade.